Pathstone Holdings’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,852
Closed -$359K 2223
2025
Q1
$359K Hold
20,852
﹤0.01% 1870
2024
Q4
$359K Buy
+20,852
New +$362K ﹤0.01% 1878
2024
Q3
Sell
-768,594
Closed -$13.5M 2351
2024
Q2
$13.5M Sell
768,594
-412,298
-35% -$7.01M 0.06% 228
2024
Q1
$20.5M Buy
1,180,892
+4,954
+0.4% +$82.9K 0.1% 147
2023
Q4
$19M Buy
+1,175,938
New +$17.9M 0.1% 141

Other funds holding ECAT

Pathstone Holdings's ECAT Position: Q2 2025 in Review

Pathstone Holdings sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q2 2025, closing a stake of 20,852 shares — an estimated $359K sold.

Pathstone Holdings first reported a position in ECAT in Q4 2023 and held it in 5 quarters. The position peaked at $20.5M in Q1 2024. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2025.

  • Pathstone Holdings reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 20,852 BlackRock ESG Capital Allocation Term Trust shares in Q2 2025, an estimated $359K.
  • Pathstone Holdings first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's BlackRock ESG Capital Allocation Term Trust position peaked at $20.5M in Q1 2024.
  • 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.